Low awareness of medication-related osteonecrosis of the jaw among dentists: a systematic review with a medical and bioethical perspective
Authors:
Open Access
- 16 January 2026
- journal article
- review article
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
Abstract
Medication-related osteonecrosis of the Jaw (MRONJ) is a serious adverse drug reaction that can seriously affect the quality of life of patients if not proKeywords
This publication has 58 references indexed in Scilit:
- Letter to Editor regarding “Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?”Osteoporosis International, 2024
- Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw – A web-based surveyJournal of Dental Sciences, 2023
- The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienistsSupportive Care in Cancer, 2022
- Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic PatientsInternational Dental Journal, 2021
- Dentists' knowledge about medication-related osteonecrosis of the jaw and its managementHeliyon, 2020
- Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental societyJournal of Cranio-Maxillofacial Surgery, 2019
- A Casebook in Interprofessional Ethics2016
- Small studies are more heterogeneous than large ones: a meta-meta-analysisJournal of Clinical Epidemiology, 2015
- Knowledge, Practices, and Opinions of Ontario Dentists When Treating Patients Receiving BisphosphonatesJournal of Oral and Maxillofacial Surgery, 2015
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014